Kashi Pharmaceuticals Government Tender Profile

With a substantial portfolio of 198 government tender participations, Kashi Pharmaceuticals has demonstrated strategic engagement in India's public procurement landscape. This analysis provides insights into their bidding performance, tender success patterns, and competitive positioning in government contracts.

Proven L1 Bid Success with 26 Contract Wins

Kashi Pharmaceuticals has successfully secured 26 L1 positions in government tenders, demonstrating their strategic pricing approach and competitive bid strategy. With a win ratio of 13.1% across 198 tender participations, they have established a reliable track record in government procurement. Their bidding performance also includes 0 L2 and 0 L3 rankings, showing consistent competitiveness in public sector contracts.

Notably, Kashi Pharmaceuticals has demonstrated capability in high-value government contracts, participating in 27 major procurement projects. This experience with premium government tenders indicates their capacity to handle significant public sector work and complex project requirements.

Financial Performance in Government Tenders

Kashi Pharmaceuticals has bid on contracts with a total value of ₹1,72,16,99,352.0, successfully securing ₹1,72,16,99,352.0 in government contract value. This represents a 100.0% conversion rate of bid value to won contracts, demonstrating their effectiveness in targeting and securing valuable public sector projects.

The company's average Earnest Money Deposit (EMD) of ₹4,85,620.5714285714 indicates their financial capacity to participate in substantial government tenders requiring significant bid security.